{"id":"W2322956806","doi":"10.1097/01.cot.0000292093.23682.2a","title":"Use of Pemetrexed (Alimta) for NSCLC Gets ODAC Recommendation for Accelerated, Although Not Full, Approval","year":2004,"lang":"en","type":"article","venue":"Oncology Times","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pemetrexed; Medicine; Docetaxel; Clinical trial; Lung cancer; Oncology; Internal medicine; Approved drug; Drug; Cancer; Pharmacology; Cisplatin; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007022974,0.0005004706,0.0005758876,0.0006901832,0.001963921,0.003601705,0.001643306,0.01481279,0.01813518],"category_scores_gemma":[0.01296017,0.0005005367,0.001334398,0.0005339063,0.00143597,0.001822835,0.001128551,0.01468488,0.0150625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002161717,"about_ca_system_score_gemma":0.008037904,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00802719,"about_ca_topic_score_gemma":0.01863181,"domain_scores_codex":[0.9928378,0.001325638,0.0006614428,0.0007600994,0.003594023,0.0008209727],"domain_scores_gemma":[0.9837875,0.002436131,0.001338998,0.0009346202,0.008079529,0.003423147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005247612,0.00004299625,0.0003959166,0.00006341738,0.00001023342,0.000122023,0.00002362937,0.00002046891,0.0008321109,0.001302048,0.9706345,0.02650018],"study_design_scores_gemma":[0.00006553537,0.00006030237,0.001231287,0.00009453523,0.00001133815,0.0002543608,0.00002304757,0.00004200668,0.0002871161,0.0003625579,0.9975556,0.00001220859],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003939773,0.01507746,0.002503194,0.7828298,0.05055967,0.0003792082,0.0009738482,0.0007314823,0.1430056],"genre_scores_gemma":[0.02338437,0.01114649,0.005972032,0.7410868,0.03330912,0.000329359,0.001526834,0.0003141417,0.1829308],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01813518,"threshold_uncertainty_score":0.06066823,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1357765585655567,"score_gpt":0.3200303274830376,"score_spread":0.1842537689174808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}